跳至主要内容
临床试验/CTRI/2020/09/027642
CTRI/2020/09/027642尚未招募未知

Impact of corona virus pandemic on the management of patients with Urological Malignancies. - CVUM

Dr Ganesh Bakshi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients registered with TMH Uro-Oncology DMG with known or suspected Prostate/Bladder/Kidney cancers. These will include new patients registered before and after the lockdown started upto one month post complete lifting of the lockdown and
  • 2.Who fall in one of the following categories:
  • i.Registered before lockdown and were in the investigations phase
  • ii.Registered before lockdown and were in the treatment planning phase
  • iii.Patients who had their treatment planned before lockdown and were having prior appointment for a scheduled therapy at TMH during lock down period.
  • iv.Patients who had completed their treatment before lockdown and were having prior appointment for a scheduled follow-up at TMH during lock down period.
  • v.All patients who: were advised follow-up (but no appointment taken by patient) for a date during the lockdown and also did not consult on phone/email and visit the Uro-oncology DMG within one month of the complete lifting of the lockdown and whose names may or may not generated from any of the lists (IT/OPD/ROIS/MOIS) will be considered as eligible for the study.
  • vi.All patients who register and visit the Uro-oncology DMG within one month of the complete lifting of the lockdown and who have any report (indicative of cancer) or referral letter for TMH but whose names were not generated from any of the lists (IT/OPD/ROIS/MOIS) will be considered as eligible for the study, if the report or referral letter is dated anytime from March 2020 onwards.
  • vii.The new patients who visited TMH personally or consulted on phone/email during lockdown and were advised investigations but could not make it to the treatment planning joint clinic (for any of the following reasons like: their inability to visit TMH due to lockdown / inability to visit TMH due to patient of relative suffering from Covid / non-functional diagnostic services at TMH / financial reasons / non-functional diagnostic or treatment services at outside TMH hospitals) will be considered as eligible if they do visit TMH or could be contacted on phone within one month of complete lifting of lockdown.
  • The case numbers of patients will be captured from the IT department and OPD records. Additionally, case numbers of patients waitlisted for surgery, radiation therapy and chemotherapy would be sought from EMR, ROIS, MOIS and other paper documented records

排除标准

  • 1.Not falling in above criteria,
  • 2.The new patients who visited TMH personally or consulted on phone/email and were advised investigations but could not make it to the treatment planning joint clinic (for any of the following reasons like: their inability to visit TMH due to lockdown / inability to visit TMH due to patient of relative suffering from Covid / non-functional diagnostic services at TMH / financial reasons / non-functional diagnostic or treatment services at outside TMH hospitals) will be considered as not eligible if they do not visit even within one month of complete lifting of lockdown.
  • 3.All patients who register and visit the Uro-oncology DMG within one month of the complete lifting of the lockdown and who have any report (indicative of cancer) or referral letter for TMH but whose names were not generated from any of the lists (IT/OPD/ROIS/MOIS) will be considered as not eligible for the study, if the report or referral letter is dated before March 2020 will not be eligible for the study.

研究者

发起方
Dr Ganesh Bakshi

相似试验